KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novavax (NVAX) Accounts Payables: 2009-2025

Historic Accounts Payables for Novavax (NVAX) over the last 16 years, with Sep 2025 value amounting to $15.2 million.

  • Novavax's Accounts Payables fell 73.53% to $15.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.2 million, marking a year-over-year decrease of 73.53%. This contributed to the annual value of $41.6 million for FY2024, which is 68.65% down from last year.
  • According to the latest figures from Q3 2025, Novavax's Accounts Payables is $15.2 million, which was down 69.90% from $50.6 million recorded in Q2 2025.
  • Novavax's 5-year Accounts Payables high stood at $386.5 million for Q2 2022, and its period low was $15.2 million during Q3 2025.
  • Its 3-year average for Accounts Payables is $71.2 million, with a median of $57.7 million in 2024.
  • As far as peak fluctuations go, Novavax's Accounts Payables spiked by 4,411.72% in 2021, and later slumped by 77.43% in 2023.
  • Novavax's Accounts Payables (Quarterly) stood at $127.0 million in 2021, then spiked by 70.42% to $216.5 million in 2022, then tumbled by 38.75% to $132.6 million in 2023, then tumbled by 68.65% to $41.6 million in 2024, then tumbled by 73.53% to $15.2 million in 2025.
  • Its Accounts Payables was $15.2 million in Q3 2025, compared to $50.6 million in Q2 2025 and $34.2 million in Q1 2025.